Ischemic Stroke and Cancer: Stroke Severely Impacts Cancer Patients, While Cancer Increases the Number of Strokes

Background Cancer and ischemic stroke are two of the most common causes of death among the elderly, and associations between them have been reported. However, the main pathomechanisms of stroke in cancer patients are not well known, and can only be established based on accurate knowledge of the characteristics of cancer-related strokes. We review herein recent studies concerning the clinical, laboratory, and radiological features of patients with cancer-related stroke. Main Contents This review covers the epidemiology, underlying mechanisms, and acute and preventive treatments for cancer-related stroke. First, the characteristics of stroke (clinical and radiological features) and systemic cancer (type and extent) in patients with cancer-specific stroke are discussed. Second, the role of laboratory tests in the early identification of patients with cancer-specific stroke is discussed. Specifically, serum D-dimer levels (as a marker of a hypercoagulable state) and embolic signals on transcranial Doppler (suggestive of embolic origin) may provide clues regarding changes in the levels of coagulopathy related to cancer and anticoagulation. Finally, strategies for stroke treatment in cancer patients are discussed, emphasizing the importance of preventive strategies (i.e., the use of anticoagulants) over acute revascularization therapy in cancer-related stroke. Conclusion Recent studies have revealed that the characteristics of cancer-related stroke are distinct from those of conventional stroke. Our understanding of the characteristics of cancer-related stroke is essential to the correct management of these patients. The studies presented in this review highlight the importance of a personalized approach in treating stroke patients with cancer.

[1]  Ji Won Kim,et al.  Coagulopathy and embolic signal in cancer patients with ischemic stroke , 2010, Annals of neurology.

[2]  A. Kakkar,et al.  Cancer-associated thrombosis , 2010, British Journal of Cancer.

[3]  C. Chung,et al.  Ischemic Stroke in Cancer Patients With and Without Conventional Mechanisms: A Multicenter Study in Korea , 2010, Stroke.

[4]  L. Rogers.  Cerebrovascular complications in patients with cancer. , 2004, Seminars in neurology.

[5]  S. Barni,et al.  Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. , 2009, The Lancet. Oncology.

[6]  O. Bang.  Multimodal MRI for Ischemic Stroke: From Acute Therapy to Preventive Strategies , 2009, Journal of clinical neurology.

[7]  A. Khorana,et al.  New Insights Into Cancer-Associated Thrombosis , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[8]  M. Carrier,et al.  Prophylactic and therapeutic anticoagulation for thrombosis—major issues in oncology , 2009, Nature Clinical Practice Oncology.

[9]  W. Struhal,et al.  Stroke and cancer: a review , 2009, Acta neurologica Scandinavica.

[10]  R. Andriantsitohaina,et al.  Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer. , 2008, Physiological research.

[11]  A. Varki.  Trousseau's syndrome: multiple definitions and multiple mechanisms. , 2007, Blood.

[12]  B. Yoon,et al.  Stroke as the first manifestation of concealed cancer , 2007, Journal of the Neurological Sciences.

[13]  S. Eichinger,et al.  Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer , 2006, Thrombosis and Haemostasis.

[14]  W. T. Hung,et al.  Risk Factor, Pattern, Etiology and Outcome in Ischemic Stroke Patients with Cancer: A Nested Case-Control Study , 2006, Cerebrovascular Diseases.

[15]  D. Cordato,et al.  Stroke risk factor, pattern and outcome in patients with cancer , 2006, Acta neurologica Scandinavica.

[16]  Scott Hamilton,et al.  Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study , 2006, Annals of neurology.

[17]  J Ratajczak,et al.  Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.

[18]  D. Sander,et al.  Embolic Signals in Unselected Stroke Patients: Prevalence and Diagnostic Benefit , 2006, Stroke.

[19]  K. Rau,et al.  Incidence of ischemic stroke post-chemotherapy: A retrospective review of 10,963 patients , 2006, Clinical Neurology and Neurosurgery.

[20]  P. Lee,et al.  Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  S. Shirasawa,et al.  Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. , 2005, Blood.

[22]  J. Rak,et al.  Shedding of tissue factor (TF)‐containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells , 2004, Journal of thrombosis and haemostasis : JTH.

[23]  M. Dewhirst,et al.  Circulating D‐dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma , 2004, Cancer.

[24]  L. Deangelis,et al.  Stroke in patients with cancer , 2004, Neurology.

[25]  F. Graus,et al.  Cerebrovascular Complications in Patients with Cancer , 1985, Seminars in neurology.

[26]  Steven Patierno,et al.  Tissue factor, thrombin, and cancer. , 2003, Chest.

[27]  M. Prins,et al.  Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. , 2003, The New England journal of medicine.

[28]  D. Ferrigno,et al.  Plasma levels of D‐dimer in lung carcinoma , 2003, Cancer.

[29]  M. Prins,et al.  The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis. , 2002, Archives of internal medicine.

[30]  F. Buonanno,et al.  Acute Ischemic Stroke Patterns in Infective and Nonbacterial Thrombotic Endocarditis: A Diffusion-Weighted Magnetic Resonance Imaging Study , 2002, Stroke.

[31]  P. V. van Dam,et al.  Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer , 2002, British Journal of Cancer.

[32]  G. Schlaug,et al.  Multiple acute stroke syndrome , 2000, Neurology.

[33]  L. Recht,et al.  Should Cerebral Ischemic Events in Cancer Patients Be Considered a Manifestation of Hypercoagulability? , 1994, Stroke.